Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...
Bladder cancer frequently announces itself through symptoms that patients dismiss as minor urinary issues, and that delay ...
- In women with pelvic organ prolapse (POP) and stress urinary incontinence (SUI), continence surgery at the same time as POP surgery likely improves rates of SUI after surgery. In continent women ...